Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who compensate us for users that Invezz refers to their services. While our reviews and assessments of each product on the site are independent and unbiased, brands may pay to appear higher up our table rankings or place ads in specific areas of the site. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
Canopy Growth Corp (TSE:WEED)
|Dividend Rate (ttm)||0.0000|
|Trading Day||Jul 22|
|Day's Range||24.72 - 28.76|
|52 Week Range||18.44 - 71.6|
Canopy Growth Corp earnings reports (2020)
|Q2 2021||Q1 2021|
|Number of Estimates||10||11|
|EPS Surprise Dollar||0.26641598343849||0.15525197982788|
|EPS Report Date||09-11-2020||10-08-2020|
|Fiscal End Date||30-09-2020||30-06-2020|
|Year Ago % Change||-91.666666666667%||-91.891891674198%|
Canopy Growth Corp dividends
Canopy Growth Corporation has a market cap or net worth of $9.80 billion. The enterprise value is $9.19 billion.
Canopy Growth Corporation has 393.12 million shares outstanding.
The trailing PE ratio is -7.0225 and the forward PE ratio is -30.0975. Canopy Growth Corporation's PEG ratio is 0.1795.
Stock Price Statistics
The stock price has decreased by -0.2114%. The beta is 0.0000, so Canopy Growth Corporation's price volatility has been lower than the market average.
In the last 12 months, Canopy Growth Corporation had revenue of $481.15 million and earned $101.04 million in profits. Earnings per share was $-3.72.
Canopy Growth is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation,the Company offers product varieties in high quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel.
Its global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. Through its award-winning Tweed and Tokyo Smoke banners, the Company reach its adult-use consumers and hasbuilt a loyal following by focusing on top quality products and meaningful customer relationships.
Canopy Growth has entered into the health and wellness consumer space in key markets including Canada, the United States, and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional federally-permissible CBD products to the United States through its First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands..